Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers

Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers. Biopsies were taken from the vastus lateralis muscle of 26 chronic uremic patients before and after a 24-week treatment with L-carnitine given at the dose of 2g i.v. at the end of hemodialysis, or in dialysis solution,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney international 1994-12, Vol.46 (6), p.1616-1619
Hauptverfasser: Giovenali, Paolo, Fenocchio, Daniela, Montanari, Giuseppe, Cancellotti, Corrado, D'Iddio, Stefania, Buoncristiani, Umberto, Pelagaggia, Maurizio, Ribacchi, Rodolfo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1619
container_issue 6
container_start_page 1616
container_title Kidney international
container_volume 46
creator Giovenali, Paolo
Fenocchio, Daniela
Montanari, Giuseppe
Cancellotti, Corrado
D'Iddio, Stefania
Buoncristiani, Umberto
Pelagaggia, Maurizio
Ribacchi, Rodolfo
description Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers. Biopsies were taken from the vastus lateralis muscle of 26 chronic uremic patients before and after a 24-week treatment with L-carnitine given at the dose of 2g i.v. at the end of hemodialysis, or in dialysis solution, or per os twice daily. The aim of the study was to evaluate both the muscle morphology in dialyzed subjects and the modification provoked by the therapy. All patients manifested a significant, even if variable, degree of muscular atrophy which involved all types of muscle fibers. After the treatment there was an increase of about 7% in the diameter of type I and type IIa fibers, which can utilize carnitine for fatty acid oxidation to produce energy, and a reduction in the atrophic fibers. No noteworthy changes were documented in type lib fibers, which depend on glycolysis for energy production.
doi_str_mv 10.1038/ki.1994.460
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77795986</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0085253815587413</els_id><sourcerecordid>77795986</sourcerecordid><originalsourceid>FETCH-LOGICAL-c433t-eeb1c2a7cacf177203d76f64e9c0de306ac93e80486ea10030259f4320d958293</originalsourceid><addsrcrecordid>eNptkEtLAzEUhYMotVZXroWs3MjUm8lkMllK8VEoKKjrkGZuMHYeNZkW-u9NaXHl6j7OuQfuR8g1gykDXt2v_JQpVUyLEk7ImImcZ0wKcUrGAJXIcsGrc3IR4zekWXEYkZGUqWdqTN7esUE7-C3SIfTrL28pOpc2tHd0kVkTOj_4Dqnv6LBbI51T09V0Pjc0rtLpYBrabqJtkDq_xBAvyZkzTcSrY52Qz6fHj9lLtnh9ns8eUmTB-ZAhLpnNjbTGOiZlDryWpSsLVBZq5FAaqzhWUFQlGgbAIRfKFTyHWokqV3xCbg-569D_bDAOuvXRYtOYDvtN1FJKJVRVJuPdwWhDH2NAp9fBtybsNAO956dXXu_56cQvuW-OsZtli_Wf9wgs6eKgY_pt6zHoaD12FmsfEjVd9_7f3F_WoHvc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77795986</pqid></control><display><type>article</type><title>Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Giovenali, Paolo ; Fenocchio, Daniela ; Montanari, Giuseppe ; Cancellotti, Corrado ; D'Iddio, Stefania ; Buoncristiani, Umberto ; Pelagaggia, Maurizio ; Ribacchi, Rodolfo</creator><creatorcontrib>Giovenali, Paolo ; Fenocchio, Daniela ; Montanari, Giuseppe ; Cancellotti, Corrado ; D'Iddio, Stefania ; Buoncristiani, Umberto ; Pelagaggia, Maurizio ; Ribacchi, Rodolfo</creatorcontrib><description>Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers. Biopsies were taken from the vastus lateralis muscle of 26 chronic uremic patients before and after a 24-week treatment with L-carnitine given at the dose of 2g i.v. at the end of hemodialysis, or in dialysis solution, or per os twice daily. The aim of the study was to evaluate both the muscle morphology in dialyzed subjects and the modification provoked by the therapy. All patients manifested a significant, even if variable, degree of muscular atrophy which involved all types of muscle fibers. After the treatment there was an increase of about 7% in the diameter of type I and type IIa fibers, which can utilize carnitine for fatty acid oxidation to produce energy, and a reduction in the atrophic fibers. No noteworthy changes were documented in type lib fibers, which depend on glycolysis for energy production.</description><identifier>ISSN: 0085-2538</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1038/ki.1994.460</identifier><identifier>PMID: 7700019</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Carnitine - blood ; Carnitine - metabolism ; Carnitine - therapeutic use ; Energy Metabolism - drug effects ; Female ; Humans ; Hypertrophy ; Male ; Middle Aged ; Muscle Contraction - drug effects ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - pathology ; Muscle, Skeletal - physiopathology ; Muscular Atrophy - drug therapy ; Muscular Atrophy - pathology ; Muscular Atrophy - prevention &amp; control ; Renal Dialysis ; Safety ; Space life sciences ; Uremia - drug therapy ; Uremia - pathology ; Uremia - physiopathology</subject><ispartof>Kidney international, 1994-12, Vol.46 (6), p.1616-1619</ispartof><rights>1994 International Society of Nephrology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c433t-eeb1c2a7cacf177203d76f64e9c0de306ac93e80486ea10030259f4320d958293</citedby><cites>FETCH-LOGICAL-c433t-eeb1c2a7cacf177203d76f64e9c0de306ac93e80486ea10030259f4320d958293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7700019$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Giovenali, Paolo</creatorcontrib><creatorcontrib>Fenocchio, Daniela</creatorcontrib><creatorcontrib>Montanari, Giuseppe</creatorcontrib><creatorcontrib>Cancellotti, Corrado</creatorcontrib><creatorcontrib>D'Iddio, Stefania</creatorcontrib><creatorcontrib>Buoncristiani, Umberto</creatorcontrib><creatorcontrib>Pelagaggia, Maurizio</creatorcontrib><creatorcontrib>Ribacchi, Rodolfo</creatorcontrib><title>Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers</title><title>Kidney international</title><addtitle>Kidney Int</addtitle><description>Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers. Biopsies were taken from the vastus lateralis muscle of 26 chronic uremic patients before and after a 24-week treatment with L-carnitine given at the dose of 2g i.v. at the end of hemodialysis, or in dialysis solution, or per os twice daily. The aim of the study was to evaluate both the muscle morphology in dialyzed subjects and the modification provoked by the therapy. All patients manifested a significant, even if variable, degree of muscular atrophy which involved all types of muscle fibers. After the treatment there was an increase of about 7% in the diameter of type I and type IIa fibers, which can utilize carnitine for fatty acid oxidation to produce energy, and a reduction in the atrophic fibers. No noteworthy changes were documented in type lib fibers, which depend on glycolysis for energy production.</description><subject>Carnitine - blood</subject><subject>Carnitine - metabolism</subject><subject>Carnitine - therapeutic use</subject><subject>Energy Metabolism - drug effects</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertrophy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - pathology</subject><subject>Muscle, Skeletal - physiopathology</subject><subject>Muscular Atrophy - drug therapy</subject><subject>Muscular Atrophy - pathology</subject><subject>Muscular Atrophy - prevention &amp; control</subject><subject>Renal Dialysis</subject><subject>Safety</subject><subject>Space life sciences</subject><subject>Uremia - drug therapy</subject><subject>Uremia - pathology</subject><subject>Uremia - physiopathology</subject><issn>0085-2538</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkEtLAzEUhYMotVZXroWs3MjUm8lkMllK8VEoKKjrkGZuMHYeNZkW-u9NaXHl6j7OuQfuR8g1gykDXt2v_JQpVUyLEk7ImImcZ0wKcUrGAJXIcsGrc3IR4zekWXEYkZGUqWdqTN7esUE7-C3SIfTrL28pOpc2tHd0kVkTOj_4Dqnv6LBbI51T09V0Pjc0rtLpYBrabqJtkDq_xBAvyZkzTcSrY52Qz6fHj9lLtnh9ns8eUmTB-ZAhLpnNjbTGOiZlDryWpSsLVBZq5FAaqzhWUFQlGgbAIRfKFTyHWokqV3xCbg-569D_bDAOuvXRYtOYDvtN1FJKJVRVJuPdwWhDH2NAp9fBtybsNAO956dXXu_56cQvuW-OsZtli_Wf9wgs6eKgY_pt6zHoaD12FmsfEjVd9_7f3F_WoHvc</recordid><startdate>19941201</startdate><enddate>19941201</enddate><creator>Giovenali, Paolo</creator><creator>Fenocchio, Daniela</creator><creator>Montanari, Giuseppe</creator><creator>Cancellotti, Corrado</creator><creator>D'Iddio, Stefania</creator><creator>Buoncristiani, Umberto</creator><creator>Pelagaggia, Maurizio</creator><creator>Ribacchi, Rodolfo</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19941201</creationdate><title>Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers</title><author>Giovenali, Paolo ; Fenocchio, Daniela ; Montanari, Giuseppe ; Cancellotti, Corrado ; D'Iddio, Stefania ; Buoncristiani, Umberto ; Pelagaggia, Maurizio ; Ribacchi, Rodolfo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c433t-eeb1c2a7cacf177203d76f64e9c0de306ac93e80486ea10030259f4320d958293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Carnitine - blood</topic><topic>Carnitine - metabolism</topic><topic>Carnitine - therapeutic use</topic><topic>Energy Metabolism - drug effects</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertrophy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - pathology</topic><topic>Muscle, Skeletal - physiopathology</topic><topic>Muscular Atrophy - drug therapy</topic><topic>Muscular Atrophy - pathology</topic><topic>Muscular Atrophy - prevention &amp; control</topic><topic>Renal Dialysis</topic><topic>Safety</topic><topic>Space life sciences</topic><topic>Uremia - drug therapy</topic><topic>Uremia - pathology</topic><topic>Uremia - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Giovenali, Paolo</creatorcontrib><creatorcontrib>Fenocchio, Daniela</creatorcontrib><creatorcontrib>Montanari, Giuseppe</creatorcontrib><creatorcontrib>Cancellotti, Corrado</creatorcontrib><creatorcontrib>D'Iddio, Stefania</creatorcontrib><creatorcontrib>Buoncristiani, Umberto</creatorcontrib><creatorcontrib>Pelagaggia, Maurizio</creatorcontrib><creatorcontrib>Ribacchi, Rodolfo</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giovenali, Paolo</au><au>Fenocchio, Daniela</au><au>Montanari, Giuseppe</au><au>Cancellotti, Corrado</au><au>D'Iddio, Stefania</au><au>Buoncristiani, Umberto</au><au>Pelagaggia, Maurizio</au><au>Ribacchi, Rodolfo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers</atitle><jtitle>Kidney international</jtitle><addtitle>Kidney Int</addtitle><date>1994-12-01</date><risdate>1994</risdate><volume>46</volume><issue>6</issue><spage>1616</spage><epage>1619</epage><pages>1616-1619</pages><issn>0085-2538</issn><eissn>1523-1755</eissn><abstract>Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers. Biopsies were taken from the vastus lateralis muscle of 26 chronic uremic patients before and after a 24-week treatment with L-carnitine given at the dose of 2g i.v. at the end of hemodialysis, or in dialysis solution, or per os twice daily. The aim of the study was to evaluate both the muscle morphology in dialyzed subjects and the modification provoked by the therapy. All patients manifested a significant, even if variable, degree of muscular atrophy which involved all types of muscle fibers. After the treatment there was an increase of about 7% in the diameter of type I and type IIa fibers, which can utilize carnitine for fatty acid oxidation to produce energy, and a reduction in the atrophic fibers. No noteworthy changes were documented in type lib fibers, which depend on glycolysis for energy production.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>7700019</pmid><doi>10.1038/ki.1994.460</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0085-2538
ispartof Kidney international, 1994-12, Vol.46 (6), p.1616-1619
issn 0085-2538
1523-1755
language eng
recordid cdi_proquest_miscellaneous_77795986
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Carnitine - blood
Carnitine - metabolism
Carnitine - therapeutic use
Energy Metabolism - drug effects
Female
Humans
Hypertrophy
Male
Middle Aged
Muscle Contraction - drug effects
Muscle, Skeletal - drug effects
Muscle, Skeletal - pathology
Muscle, Skeletal - physiopathology
Muscular Atrophy - drug therapy
Muscular Atrophy - pathology
Muscular Atrophy - prevention & control
Renal Dialysis
Safety
Space life sciences
Uremia - drug therapy
Uremia - pathology
Uremia - physiopathology
title Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T17%3A43%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective%20trophic%20effect%20of%20L-carnitine%20in%20type%20I%20and%20IIa%20skeletal%20muscle%20fibers&rft.jtitle=Kidney%20international&rft.au=Giovenali,%20Paolo&rft.date=1994-12-01&rft.volume=46&rft.issue=6&rft.spage=1616&rft.epage=1619&rft.pages=1616-1619&rft.issn=0085-2538&rft.eissn=1523-1755&rft_id=info:doi/10.1038/ki.1994.460&rft_dat=%3Cproquest_cross%3E77795986%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77795986&rft_id=info:pmid/7700019&rft_els_id=S0085253815587413&rfr_iscdi=true